Ken Griffin Amphastar Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,900 shares of AMPH stock, worth $604,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,900
Previous 11,300
31.86%
Holding current value
$604,642
Previous $698,000
6.3%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding AMPH
# of Institutions
277Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$247 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$111 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$84.3 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$67.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$61.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.99B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...